CMS Promotes Competition, Transparency, Health Equity and More in the CY2025 Medicare Advantage and Part D Proposed Rule
CMS Promotes Competition, Transparency, Health Equity and More in the CY2025 Medicare Advantage and Part D Proposed Rule
At a Glance: Legal Efforts to Limit Discrimination Through AI
At a Glance: Legal Efforts to Limit Discrimination Through AI
340B Drug Pricing Discount Program Update: HRSA Now Demands That Drug Manufacturers Provide 340B Discounts To Contract Pharmacies Amid Ongoing Litigation
CMS’ Next Generation Accountable Care Organization (NGACO) Model Set To End in December 2021
CMS Proposes Repeal of Certain Cost Reporting Requirements from the IPPS Final Rule for 2021
“Hope Is On The Horizon”: California Governor Gavin Newsom Announces COVID-19 Vaccine Distribution Plan
